Klompas Neil A bought INM
October 17, 2025 · Form 4 insider transaction
Klompas Neil A bought 3,500 shares of InMed Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,500
Price
$0.00
Total value
N/A
InsiderKlompas Neil A
Role—
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 17, 2025
Filing dateOctober 21, 2025
Shares owned after3,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
(1) The options were granted on Oct 17, 2025 and will vest monthly, in arrears, as follows: (i) 98 stock options will vest on the 17th day of each month for 35 months, and (ii) 70 stock options will vest on Oct 17, 2025 (the three year anniversary of Grant date).